论文部分内容阅读
近年来,抗HBc-IgM不仅被作为急性乙型肝炎初期感染的病原学诊断依据,而且被看作是肝炎慢性不愈的指标。为此,笔者对196例乙型慢性活动型肝炎(CAHB)患者进行了抗HBc-IgM测定,并与乙肝病毒(HBV)复制指标(HBeAg、PHSA受体、HBVDNA)相比较,现将结果报告如下。临床资料一、对象 196例均系住院病人,其中男158例、女38例,年龄17～67岁,其诊断均符合1984年全国肝炎学术会议制定的标准,为慢性活动型,53例已经肝穿病理证实。二、方法 1.HBeAg、抗HBc-IgM、PHSA受
In recent years, anti-HBc-IgM is not only used as an etiological basis for the diagnosis of acute hepatitis B infection, but also as an indicator of chronic hepatitis. To this end, the author of 196 cases of chronic hepatitis B patients with chronic hepatitis (CAHB) were measured anti-HBc-IgM and hepatitis B virus replication markers (HBeAg, PHSA receptor, HBVDNA) compared to the results reported as follows. Clinical data First, the object of 196 cases were hospitalized patients, including 158 males and 38 females, aged 17 to 67 years of age, the diagnosis is in line with the 1984 National Conference on hepatitis standards for the development of chronic active type, 53 cases of liver Wear pathology confirmed. Second, the method 1. HBeAg, anti-HBc-IgM, PHSA by